Restless legs syndrome

British Medical Journal

Volumn 333, Issue 7566, 2006, Pages 457-458

  Medcalf, P ^a   Bhatia, K P ^b  

^a CHESTERFIELD ROYAL HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CABERGOLINE; CARBAMAZEPINE; CLONAZEPAM; DOMPERIDONE; DOPAMINE RECEPTOR STIMULATING AGENT; FERRITIN; GABAPENTIN; LEVODOPA; OPIATE; PERGOLIDE; PLACEBO; PRAMIPEXOLE; ROPINIROLE; ROTIGOTINE;

BRAIN REGION; CLINICAL TRIAL; DAYTIME SOMNOLENCE; DIALYSIS; DISEASE ASSOCIATION; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG HALF LIFE; EDITORIAL; FAMILY HISTORY; FERRITIN BLOOD LEVEL; HUMAN; IRON DEFICIENCY; LEG MOVEMENT; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; SYMPTOMATOLOGY; SYSTEMATIC REVIEW;

EID: 33748433143     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.333.7566.457     Document Type: Editorial

References (12)

1. Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of restless legs symptoms in adults. Arch Intern Med 2000;160:2137-41.
2. Walters AS, Picchietti DL, Ehrenberg BL, Wagner ML. Restless legs syndrome in childhood and adolescence. Ped Neurol 1994;11:241-5.
3. Walters AS. Is there a sub-population of children with growing pains who really have restless legs syndrome? A review of the literature. Sleep Med 2002;3:93-8.
4. Walters AS. Toward a better definition of the restless legs syndrome. Mov Dis 1995;10:634-42.
5. O'Keeffe ST, Gavin K, Lavan JN. Iron status and restless legs syndrome in the elderly. Age Ageing 1994;23:200-3.
6. Entezari-Taher M, Singleton JR, Jones CR, Meekins G, Petajan JH, Smith AG. Changes in excitability of motor cortical circuitry in primary restless legs syndrome. Neurology 1999;53:1201-5.
7. Trenkwalder C, Walters AS, Hening WA, Chokroverty S, Anionini A, Dhawan V. Positron emission tomographic studies in restless legs syndrome. Mov Disord 1999;14:141-5.
8. Happe S, Trenkwalder C. Role of dopamine receptor agonists in the treatment of restless legs syndrome. CNS Drugs 2004;18:27-36.
9. Benes H, Kurella B, Kummer J, Kazenwadel J, Selzer R, Kohnen R. Rapid onset of action of levodopa in restless legs syndrome: a double blind, randomised, multicenter, crossover trial. Sleep 1999;22:1073-81.
10. Montplaisir J, Nicholas A, Denesie R, Gomez-Mancilla B. Restless legs syndrome improved by pramipexole: a double-blind randomized trial. Neurology 1999;52:938-43.
11. Trenkwaider C, Garcia-Borreguero D, Montagna P, Lainey E, de Weerd AW, Tidswell P, et al. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo-controlled study in 10 European countries. J Neurol Neurosurg Psychiatry 2004;75:92-7.
12. Trenkwalder C, Hundemer HP, Lledo A, Swieca J, Polo O, Wetter TC, et al. Efficacy of pergolide in treatment of restless legs syndrome: the PEARLS study. Neurology 2004;62:1391-7.